Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-17

Clinical Trial Update: Effect of Niacinamide Supplementation in Glaucoma [NA]

View source ↗

Summary

A completed clinical trial evaluated the effects of niacinamide supplementation in primary open-angle glaucoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Niacinamide (nicotinamide)

Snippet

Sponsor: University of Medicine and Pharmacy Craiova | Conditions: Primary Open-Angle Glaucoma (POAG) | NA | Status: COMPLETED